PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
28-Jul-2020 Acacia Pharma Advances Preparations for US Launch of BARHEMSYS® Acacia Pharma Group plc
28-Jul-2020 Update on Phase 2b clinical study of lead asset XF-73 in the prevention of post-surgical bacterial infections Destiny Pharma plc
28-Jul-2020 Fund+ Leads EUR38 Million Series B Financing in Indigo Diabetes NV Fund+
28-Jul-2020 Oculis Announces Successful End-of-Phase 2 Meeting with the FDA for OCS-01 in Two Ophthalmology Indications Oculis
28-Jul-2020 CPI, the Cell and Gene Therapy Catapult and MicrofluidX announce development of technology to rapidly scale up cell and gene therapy manufacture CPI
28-Jul-2020 European Commission grants marketing authorisation for world’s first subcutaneous formulation of infliximab, Remsima® SC, for an additional five indications including for use in inflammatory bowel disease and ankylosing spondylitis Celltrion Healthcare
28-Jul-2020 Chi-Med and Lilly to Collaborate in Commercializing Elunate® in China Chi-Med
28-Jul-2020 Chi-Med’s NDA for Savolitinib in Non-Small Cell Lung Cancer Granted Priority Review in China Chi-Med
28-Jul-2020 Farxiga met all primary and secondary endpoints in groundbreaking Phase III DAPA-CKD trial for the treatment of patients with chronic kidney disease AstraZeneca
28-Jul-2020 Awarded Contract from Codagenix Inc. New York USA for COVID-19 Vaccine Trial Open Orphan plc
28-Jul-2020 Coulter Partners secures Chief Executive Officer for Optimapharm Optimapharm
28-Jul-2020 Polyphor strengthens financial flexibility with CHF 19.3 million equity-linked financing Polyphor
28-Jul-2020 MSF: COVID-19 test maker Cepheid overcharging the world’s poorest countries MSF UK
28-Jul-2020 Imfinzi recommended for approval in the EU by CHMP for extensive-stage small cell lung cancer AstraZeneca
28-Jul-2020 Study Reveals How Renegade Protein Interrupts Brain Cell Function in Alzheimer's Disease NYU Langone Health
28-Jul-2020 Rigel Announces Conference Call and Webcast to Report Second Quarter 2020 Financial Results and Business Update Rigel Pharmaceuticals, Inc.
28-Jul-2020 MindMed Completes Dosing 18-MC Phase 1 Study Mind Medicine (MindMed) Inc.
28-Jul-2020 Zsolt Lavotha has been appointed acting CEO of Swedish Biomimetics 3000® Ltd Swedish Biomimetics 3000®
28-Jul-2020 STORM Therapeutics to Present at Two Scientific Conferences in July 2020 STORM Therapeutics
28-Jul-2020 Kanazawa University research: Diverse amyloid structures and dynamics revealed by high-speed atomic force microscopy Kanazawa University